Fidelity International
RDY icon

Fidelity International’s Dr. Reddy's Laboratories RDY Stock Holding History

Fidelity International’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-234,605
Closed -$2.43M – 858
2022
Q4 		$2.43M Hold
234,605
– – ﹤0.01% 650
2022
Q3 		$2.46M Buy
+234,605
New +$2.5M ﹤0.01% 649
2017
Q2 		– Sell
-92,935
Closed -$746K – 540
2017
Q1 		$746K Sell
92,935
-61,995
-40% -$535K ﹤0.01% 501
2016
Q4 		$1.4M Sell
154,930
-105,485
-41% -$982K ﹤0.01% 479
2016
Q3 		$2.42M Buy
260,415
+415
+0.2% +$3.96K 0.01% 452
2016
Q2 		$2.66M Buy
260,000
+54,500
+27% +$499K 0.01% 440
2016
Q1 		$1.86M Hold
205,500
– – 0.01% 438
2015
Q4 		$1.9M Sell
205,500
-254,000
-55% -$2.78M 0.01% 431
2015
Q3 		$5.87M Hold
459,500
– – 0.02% 369
2015
Q2 		$5.08M Hold
459,500
– – 0.02% 415
2015
Q1 		$5.25M Sell
459,500
-3,281,755
-88% -$34.8M 0.02% 412
2014
Q4 		$37.7M Sell
3,741,255
-4,915,045
-57% -$51.7M 0.13% 165
2014
Q3 		$91M Buy
8,656,300
+832,985
+11% +$7.83M 0.35% 84
2014
Q2 		$67.5M Buy
7,823,315
+750,130
+11% +$6.31M 0.25% 103
2014
Q1 		$62.1M Buy
7,073,185
+438,825
+7% +$3.82M 0.23% 114
2013
Q4 		$54.4M Buy
6,634,360
+1,166,080
+21% +$9.23M 0.22% 120
2013
Q3 		$41.3M Buy
5,468,280
+2,202,850
+67% +$16M 0.2% 129
2013
Q2 		$24.7M Buy
+3,265,430
New +$23.8M 0.14% 170

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity International's RDY Position: Q1 2023 in Review

Fidelity International sold out of Dr. Reddy's Laboratories (RDY) in Q1 2023, closing a stake of 234,605 shares — an estimated $2.43M sold.

Fidelity International first reported a position in RDY in Q2 2013 and held it in 18 quarters. The position peaked at $91M in Q3 2014. 190 funds tracked by Wall St. Rank hold RDY as of Q1 2023.

  • Fidelity International reported no remaining Dr. Reddy's Laboratories position as of Q1 2023 after selling out during the quarter.
  • Fidelity International sold 234,605 Dr. Reddy's Laboratories shares in Q1 2023, an estimated $2.43M.
  • Fidelity International first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 18 quarters.
  • Fidelity International's Dr. Reddy's Laboratories position peaked at $91M in Q3 2014.
  • 190 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2023.

Based on Fidelity International's 13F filing for Q1 2023, filed 11 May 2023.